Global In Vitro Diagnostics Market to Surpass $94.57 Billion by 2022 - Orbis Research

According to Stratistics MRC, the Global In Vitro Diagnostics market is accounted for $61.65 billion in 2015 and is expected to reach $94.57 billion by 2022 growing at a CAGR of 6.3%. Technologically advanced healthcare and consumer spending in market is helping the market growth. Polluted environment and contaminated surroundings are leading to increase in number of chronic disease and infections, these all factors are favoring the market to grow. Moreover widely spread knowledge and cost effectiveness are also driving the market. But stringent regulations and reimbursement issues are hampering the market growth.

Browse the report: http://www.orbisresearch.com/reports/index/in-vitro-diagnostics-global-market-outlook-2015-2022

However Infectious disease in application segment is anticipated to grow at considerable pace due to rise in amount of infectious diseases and it is followed by HIV/AIDS application. Whereas Laboratories in end-user segment is estimated to grow fast because of rise in number of laboratories, followed by Point of Care Diagnostics. North America being the largest revenue market, Asia Pacific is expected to grow fast due to increasing number of End-User applications.

Some of the major key players in the market are Roche Diagnostics Bio-Rad Laboratories, Inc., Johnson and Johnson , Biomérieux, Siemens Healthcare, Abbott Laboratories, Inc., Thermo Fisher Scientific, Inc., Ortho Clinical Diagnostics, Inc., Danaher Corporation, Sysmex Corporation, Becton, Dickinson and Company, Cepheid Inc , Alere Inc., Novartis and Leica Biosystems.

Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/184740

Applications Covered:
Diabetes
Autoimmune Diseases
Cardiology
Drug Testing
HIV/AIDS
Infectious Diseases
Nephrology
Oncology/Cancer
Other Applications
Product & Services Covered:
Data Management Software/Hardware
Instruments
Reagents & Kits
Services

Technologies Covered:
Immunochemistry/Immunoassays
Elisa
Chemiluminescence Immunoassays (CLIAs)
Colorimetric Immunoassays (CI)
Fluorescence Immunoassays (FIA)
Western Blot
Rapid Tests
Radioimmunoassay’s (RIA)
Elispot
Coagulation and Hemostasis
Molecular Diagnostics (MDX)
DNA Sequencing & Next-Generation Sequencing
Hybridization
Isothermal Nucleic Acid Amplification Technology (INAAT)
Microarrays
Polymerase Chain Reaction (PCR)
Other Molecular Diagnostics
Hematology
Microbiology
Clinical Chemistry
Electrolyte Panels
Basic Metabolic Panel
Lipid Profiles
Liver Panels
Renal Profiles
Specialty Chemical Tests
Thyroid Function Panels
Other Technologies

End-Users Covered:
Academic Institutes
Hospitals
Laboratories
Patient Self-Testing
Point-Of-Care Testing
Other End-Users

Regions Covered:
North America
US
Canada
Mexico
Europe
Germany
France
Italy
UK
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
Rest of Asia Pacific
Rest of the World
Middle East
Brazil
Argentina
South Africa
Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:

Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Email: sales@orbisresearch.com

This release was published on openPR.